Antibody data
- Antibody Data
- Antigen structure
- References [32]
- Comments [0]
- Validations
- Western blot [4]
- Immunohistochemistry [1]
- Other assay [18]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 33-6400 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Bax Monoclonal Antibody (2D2)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Reactivity
- Human, Mouse
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 2D2
- Vial size
- 100 µg
- Concentration
- 0.5 mg/mL
- Storage
- -20°C
Submitted references Neural stem cell-derived exosomes suppress neuronal cell apoptosis by activating autophagy via miR-374-5p/STK-4 axis in spinal cord injury.
Identification of a novel circ_0001946/miR-1290/SOX6 ceRNA network in esophageal squamous cell cancer.
Regulation of microRNA miR-197-3p/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by Circular RNA hsa_circ_0000285 promotes glioma progression.
Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, "Naked" Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells.
The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
Circular RNA_0000629 Suppresses Bladder Cancer Progression Mediating MicroRNA-1290/CDC73.
MYBL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells.
Pristimerin inhibits neuronal inflammation and protects cognitive function in mice with sepsis-induced brain injuries by regulating PI3K/Akt signalling.
LncRNA HOXA11-AS aggravates the keloid formation by targeting miR-148b-3p/IGFBP5 axis.
Melittin induces NSCLC apoptosis via inhibition of miR-183.
Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells.
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.
A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe.
Cardiolipin or MTCH2 can serve as tBID receptors during apoptosis.
p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells.
Identification of prognostic biomarkers for glioblastomas using protein expression profiling.
Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.
Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
Cellular destruction following transmyocardial laser revascularization (TMR).
Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma.
Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma.
Pilomatrix carcinoma with lymph node metastases.
Pilomatrix carcinoma with lymph node metastases.
Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL.
BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival.
Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival.
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Zhang L, Han P
Journal of musculoskeletal & neuronal interactions 2022 Sep 1;22(3):411-421
Journal of musculoskeletal & neuronal interactions 2022 Sep 1;22(3):411-421
Identification of a novel circ_0001946/miR-1290/SOX6 ceRNA network in esophageal squamous cell cancer.
Wang J, Yao W, Li J, Zhang Q, Wei L
Thoracic cancer 2022 May;13(9):1299-1310
Thoracic cancer 2022 May;13(9):1299-1310
Regulation of microRNA miR-197-3p/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by Circular RNA hsa_circ_0000285 promotes glioma progression.
Deng T, Liu Y, Yang Y, Yuan L, Liu F, Wang X, Zhang Q, Xie M
Bioengineered 2022 Mar;13(3):4757-4772
Bioengineered 2022 Mar;13(3):4757-4772
Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, "Naked" Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells.
Varlamova EG, Goltyaev MV, Simakin AV, Gudkov SV, Turovsky EA
International journal of molecular sciences 2022 Jun 14;23(12)
International journal of molecular sciences 2022 Jun 14;23(12)
The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
Mou Y, Sun Q
Bioengineered 2022 Jan;13(1):746-758
Bioengineered 2022 Jan;13(1):746-758
Circular RNA_0000629 Suppresses Bladder Cancer Progression Mediating MicroRNA-1290/CDC73.
Wang J, Luo J, Wu X, Gao Z
Cancer management and research 2021;13:2701-2715
Cancer management and research 2021;13:2701-2715
MYBL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells.
Deng Q, Wu L, Li Y, Zou L
Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2021 Sep;30(9):957-966
Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2021 Sep;30(9):957-966
Pristimerin inhibits neuronal inflammation and protects cognitive function in mice with sepsis-induced brain injuries by regulating PI3K/Akt signalling.
Xue W, Li Y, Zhang M
Pharmaceutical biology 2021 Dec;59(1):1351-1358
Pharmaceutical biology 2021 Dec;59(1):1351-1358
LncRNA HOXA11-AS aggravates the keloid formation by targeting miR-148b-3p/IGFBP5 axis.
Wang J, Shen J
Biochemical and biophysical research communications 2021 Dec 3;581:60-67
Biochemical and biophysical research communications 2021 Dec 3;581:60-67
Melittin induces NSCLC apoptosis via inhibition of miR-183.
Gao D, Zhang J, Bai L, Li F, Dong Y, Li Q
OncoTargets and therapy 2018;11:4511-4523
OncoTargets and therapy 2018;11:4511-4523
Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells.
Plackal Adimuriyil George B, Kumar N, Abrahamse H, Ray SS
Scientific reports 2018 Sep 25;8(1):14368
Scientific reports 2018 Sep 25;8(1):14368
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.
Pollack A, Kwon D, Walker G, Khor LY, Horwitz EM, Buyyounouski MK, Stoyanova R
Journal of the National Cancer Institute 2017 Feb 1;109(2):1-8
Journal of the National Cancer Institute 2017 Feb 1;109(2):1-8
A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe.
Martinez-Castillo M, Bonilla-Moreno R, Aleman-Lazarini L, Meraz-Rios MA, Orozco L, Cedillo-Barron L, Cordova EJ, Villegas-Sepulveda N
PloS one 2016;11(11):e0165971
PloS one 2016;11(11):e0165971
Cardiolipin or MTCH2 can serve as tBID receptors during apoptosis.
Raemy E, Montessuit S, Pierredon S, van Kampen AH, Vaz FM, Martinou JC
Cell death and differentiation 2016 Jul;23(7):1165-74
Cell death and differentiation 2016 Jul;23(7):1165-74
p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells.
Piedfer M, Bouchet S, Tang R, Billard C, Dauzonne D, Bauvois B
Biochimica et biophysica acta 2013 Jun;1833(6):1316-28
Biochimica et biophysica acta 2013 Jun;1833(6):1316-28
Identification of prognostic biomarkers for glioblastomas using protein expression profiling.
Jung Y, Joo KM, Seong DH, Choi YL, Kong DS, Kim Y, Kim MH, Jin J, Suh YL, Seol HJ, Shin CS, Lee JI, Kim JH, Song SY, Nam DH
International journal of oncology 2012 Apr;40(4):1122-32
International journal of oncology 2012 Apr;40(4):1122-32
Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.
Piedfer M, Dauzonne D, Tang R, N'Guyen J, Billard C, Bauvois B
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011 Aug;25(8):2831-42
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011 Aug;25(8):2831-42
Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2006 Jun;15(3):258-65
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2006 Jun;15(3):258-65
Cellular destruction following transmyocardial laser revascularization (TMR).
Cherian SM, Bobryshev YV, Tran D, Sivaraman A, Lord RS, Cherian KM
Journal of molecular histology 2005 May;36(4):275-80
Journal of molecular histology 2005 May;36(4):275-80
Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma.
Kim LH, Nadarajah VS, Peh SC, Poppema S
Histopathology 2004 Mar;44(3):257-67
Histopathology 2004 Mar;44(3):257-67
Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma.
Kim LH, Nadarajah VS, Peh SC, Poppema S
Histopathology 2004 Mar;44(3):257-67
Histopathology 2004 Mar;44(3):257-67
Pilomatrix carcinoma with lymph node metastases.
Bassarova A, Nesland JM, Sedloev T, Danielsen H, Christova S
Journal of cutaneous pathology 2004 Apr;31(4):330-5
Journal of cutaneous pathology 2004 Apr;31(4):330-5
Pilomatrix carcinoma with lymph node metastases.
Bassarova A, Nesland JM, Sedloev T, Danielsen H, Christova S
Journal of cutaneous pathology 2004 Apr;31(4):330-5
Journal of cutaneous pathology 2004 Apr;31(4):330-5
Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL.
Gascoyne DM, Kypta RM, Vivanco Md
The Journal of biological chemistry 2003 May 16;278(20):18022-9
The Journal of biological chemistry 2003 May 16;278(20):18022-9
BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
Rassidakis GZ, Jones D, Lai R, Ramalingam P, Sarris AH, McDonnell TJ, Medeiros LJ
The Journal of pathology 2003 Jun;200(2):240-8
The Journal of pathology 2003 Jun;200(2):240-8
Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
Pagliaro LC, Keyhani A, Williams D, Woods D, Liu B, Perrotte P, Slaton JW, Merritt JA, Grossman HB, Dinney CP
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 Jun 15;21(12):2247-53
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 Jun 15;21(12):2247-53
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.
Stadheim TA, Suh N, Ganju N, Sporn MB, Eastman A
The Journal of biological chemistry 2002 May 10;277(19):16448-55
The Journal of biological chemistry 2002 May 10;277(19):16448-55
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
Sjöström J, Blomqvist C, von Boguslawski K, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Wist E, Valvere V, Takayama S, Reed JC, Saksela E
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Mar;8(3):811-6
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Mar;8(3):811-6
Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival.
Korkolopoulou P, Lazaris ACh, Konstantinidou AE, Kavantzas N, Patsouris E, Christodoulou P, Thomas-Tsagli E, Davaris P
European urology 2002 Mar;41(3):274-83
European urology 2002 Mar;41(3):274-83
Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival.
Korkolopoulou P, Lazaris ACh, Konstantinidou AE, Kavantzas N, Patsouris E, Christodoulou P, Thomas-Tsagli E, Davaris P
European urology 2002 Mar;41(3):274-83
European urology 2002 Mar;41(3):274-83
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Rassidakis GZ, Medeiros LJ, McDonnell TJ, Viviani S, Bonfante V, Nadali G, Vassilakopoulos TP, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Feb;8(2):488-93
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Feb;8(2):488-93
Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ, Kong Y, Mei B
Journal of immunology (Baltimore, Md. : 1950) 1999 Feb 15;162(4):2049-56
Journal of immunology (Baltimore, Md. : 1950) 1999 Feb 15;162(4):2049-56
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of BAX in A549 whole cell lysate (lane 1) and Daudi whole cell lysate (lane 2) using a BAX monoclonal antibody (Product # 33-6400) at a dilution of 1:100. Secondary detection was performed using an HRP-Goat anti-Mouse IgG, IgM (H+L) cross-adsorbed secondary antibody (Product # 31446) at a dilution of 1:5000. Data provided courtesy of Antibody Resource.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of BAX in A549 whole cell lysate (lane 1) and Daudi whole cell lysate (lane 2) using a BAX monoclonal antibody (Product # 33-6400) at a dilution of 1:100. Secondary detection was performed using an HRP-Goat anti-Mouse IgG, IgM (H+L) cross-adsorbed secondary antibody (Product # 31446) at a dilution of 1:5000. Data provided courtesy of Antibody Resource.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Knockout of BAX was achieved by CRISPR-Cas9 genome editing using LentiArray™ Lentiviral sgRNA (Product # A32042, Assay ID CRISPR612938_LV) and LentiArray Cas9 Lentivirus (Product # A32064). Western blot analysis of BAX was performed by loading 50 µg of HeLa Wild Type (Lane 1), HeLa Cas9 (Lane 2) andHeLa BAX KO (Lane 3) whole cell extracts. The samples were electrophoresed using Novex™ 16%, Tricine, 1.0 mm, Mini Protein Gel (Product # EC66952BOX). Resolved proteins were then transferred onto a nitrocellulose membrane (Product # IB23001) by iBlot® 2 Dry Blotting System (Product # IB21001). The blot was probed with Anti-Bax Monoclonal Antibody (2D2) (Product # 33-6400, 1:500 dilution) and Goat anti-Mouse IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP (Product # A28177, 1:5,000 dilution) using the iBright FL 1000 (Product # A32752). Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005). Loss of signal upon CRISPR mediated knockout (KO) using the LentiArray™ CRISPR product line confirms that antibody is specific to BAX.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot was performed using Anti-Bax Monoclonal Antibody (2D2)(Product # 33-6400) and a 19kDa band corresponding to Bax was observed across cell lines tested. Whole cell extracts (30 µg lysate) of MCF7 (Lane 1), MCF7 treated with Etoposide (50uM, 16 Hrs.) (Lane 2), A549 (Lane 3), A549 treated with Etoposide (50uM, 16 Hrs.) (Lane 4) were electrophoresed using NuPAGE™ 4-12% Bis-Tris Protein Gel (Product # NP0322BOX). Resolved proteins were then transferred onto a Nitrocellulose membrane (Product # IB23001) by iBlot® 2 Dry Blotting System (Product # IB21001). The blot was probed with the primary antibody (1:1000 Dilution) and detected by chemiluminescence with Goat anti-Mouse IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP (Product # A28177,1:4000) using the iBright FL 1000 (Product # A32752). Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005).Expression of BAX was found to be up regulated upon etoposide treatment in A549 and MCF-7 cells.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of Bax showing staining in the cytoplasm of paraffin-embedded mouse lymph node tissue (right) compared to a negative control without primary antibody (left). To expose target proteins, antigen retrieval was performed using 10 mM sodium citrate (pH 6.0), microwaved for 8-15 min. Following antigen retrieval, tissues were blocked in 3% H2O2-methanol for 15 min at room temperature, washed with ddH2O and PBS, and then probed with Bax Monoclonal antibody (Product # 33-6400) diluted in 3% BSA-PBS at a dilution of 1:100 overnight at 4°C in a humidified chamber. Tissues were washed extensively in PBST and detection was performed using a HRP-conjugated secondary antibody followed by colorimetric detection using a DAB kit. Tissues were counterstained with hematoxylin and dehydrated with ethanol and xylene to prep for mounting.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2 Classification of 56 patients by prognosis based on 108 protein expression values. (A) Boxplot of protein expression values before (left) and after (right) quantile normalization. The plot shows the quantile normalized distribution of protein expression values for each patient. Horizontal axis represents individual patients. Vertical axis represents H-score. (B) Heatmap and dendrogram as a result of hierarchical clustering of GBM samples. Top dendrogram represents clustering of patients. Left dendrogram represents clustering of proteins. Of two patient branches, samples in the left branch represent cluster 1 and samples in the right branch represent cluster 2, consisting of 19 and 37 patients, respectively. (C) Univariate survival analysis of overall survival by Kaplan-Meier method. Kaplan-Meier survival plot of the two clusters of patients defined by the hierarchical clustering. Cluster 1 is the poor survival group. The log-rank test shows that the difference between two curves is significant (p
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2 Overexpression of circ_0000629 inhibits the growth of BC cells in vitro. Overexpression plasmid of circ_0000629 was transfected into T24 and SW780 cells. ( A ) circ_0000629 expression in the cells examined by RT-qPCR; ( B ) CCK-8 assay to detect the activity of T24 and SW780 cells; ( C ) EdU staining for proliferative capacity of T24 and SW780 cells; ( D ) flow cytometric analysis of apoptotic T24 and SW780 cells; ( E ) Caspase-3/7 kits detection of caspase-3/7 activity in T24 and SW780 cells; ( F ) expression of apoptosis-related proteins PUMA, Bax, and Bcl-2 in cells examined by Western blot. Date are mean +- SD, n = 3. *p < 0.05, **p < 0.01, ***p < 0.001 (two-way ANOVA and Tukey''s multiple comparison test).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 6 miR-1290 mimic promotes the growth and aggressiveness of BC cells in vitro. T24 and SW780 cells were co-transfected with oe-circ_0000629 + miR-1290 mimic or oe-circ_0000629 + mimic NC. ( A ) expression of miR-1290 in cells after co-transfection by RT-qPCR; ( B ) EdU staining for proliferative capacity of T24 and SW780 cells; ( C ) flow cytometric analysis of apoptotic T24 and SW780 cells; ( D ) expression of apoptosis-related proteins PUMA, Bax, and Bcl-2 in cells examined by Western blot; ( E ) the migration capacity of T24 and SW780 cells examined by Transwell assay; ( F ) the invasion capacity of T24 and SW780 cells examined by Transwell assay. Date are mean +- SD, n = 3. ** p < 0.01 (two-way ANOVA and Tukey''s multiple comparison test).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 8 Knockdown of CDC73 attenuates the inhibitory effect of oe-circ_0000629 on BC cells. T24 and SW780 cells were co-transfected with oe-circ_0000629 + shScr, oe-circ_0000629 + shCDC73-#1 or oe-circ_0000629 + shCDC73-#2. ( A ) mRNA expression of CDC73 in cells after co-transfection by RT-qPCR; ( B ) protein expression of CDC73 in cells after co-transfection by Western blot; ( C ) EdU staining for proliferative capacity of T24 and SW780 cells; ( D ) flow cytometric analysis of apoptotic T24 and SW780 cells; ( E ) expression of apoptosis-related proteins PUMA, Bax, and Bcl-2 in cells examined by Western blot; ( F ) the migration capacity of T24 and SW780 cells examined by Transwell assay; ( G ) the invasion capacity of T24 and SW780 cells examined by Transwell assay. Date are mean +- SD, n = 3. ** p < 0.01 (two-way ANOVA and Tukey''s multiple comparison test).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 4. Pristimerin ameliorates neuronal cell apoptosis in brain tissue homogenates of mice with sepsis-induced brain injuries. (A) Effects of pristimerin on expression levels of Bax, Bcl-2 and caspase-3, as revealed by Western blotting. (B) Effect of pristimerin on the apoptosis index, as revealed by the TUNEL assay. TUNEL: terminal deoxynucleotidyl transferase dUTP nick end-labelling. Means +- SEMs ( n = 10); ## p < 0.01 compared with positive controls; ** p < 0.01 compared with negative controls.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2. ASMTL-AS1 downregulation inhibits HCC proliferation and migration in vitro. a. qRT-PCR analysis of ASMTL-AS1 expression in HCC cell lines and THLE2 cells. b. qRT-PCR analysis of ASMTL-AS1 expression in HCC tissues and normal tissues. c. ASMTL-AS1 mainly located in cytoplasm. d. The effects of transfection of siASMTL-AS1 and si-NC in HCC cell lines (HCCLM3 and Huh7 cells) were detected by PCR analysis. e. CCK-8 assay was performed to test the cell viability and proliferation in downregulated CASMTL-AS1 groups (si-ASMTL-AS1) and negative control group (si-NC). f. Western blotting analysis was performed to detect the Bax and Bcl-2 expression in HCCLM3 and Huh7 cells. G. Transwell assay was performed the migrated and invaded abilities in HCC cell lines. * P < 0.05, ** P < 0.001, vs. Si-NC. H. ASMTL-AS1 downregulation inhibited HCC tumor growth in vivo. ** P < 0.001, vs. Sh-NC.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 4. MiR-1343-3p inhibitor abrogates the deceleration of HCC cell proliferation and migration caused by ASMTL-AS1 silence. HCCLM3 and Huh cells transfected with si-NC, si-ASMTL-AS1, miR-1343-3p inhibitor, inhibitor NC, si-ASMTL-AS1+ miR-1343-3p inhibitor. a. Proliferation test by CCK8 assay. b. Western blot detection of Bcl-2 and Bax. d. Migration was assessed using transwell migration assays. * P < 0.05,** P < 0.001,vs.Si-NC; #P < 0.05, ## P < 0.001, vs.inhibitor-NC; DeltaP
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 6. LAMC1 silence attenuates the accelerated proliferation and migration of HCC cells caused by miR-1343-3p inhibitor. HCCLM3 and Huh7 were transfected with si-NC, si-LAMC1, miR-1343-3p inhibitor, inhibitor NC and si-LAMC1+ miR-1343-3p inhibitor. After 48 h transfection, a. CCK8 to detect cell proliferation change. b. Western blot and Western blot analysis of Bax and Bcl-2 protein expression. c. Migration was assessed using transwell migration assays. *P < 0.05, **P < 0.001, vs.Si-NC; # P < 0.05, ## P < 0.001, vs. inhibitor-NC; DeltaP
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 2 FIGURE Circ_0001946 expression affects cell proliferation, invasion, migration and apoptosis in vitro. (a-h) ECA109 and KYSE450 cells were introduced with vector control or a recombinant plasmid expressing circ_0001946 (oe-circ_0001946). (a) qRT-PCR validating the circ_0001946 upregulation efficacy of oe-circ_0001946 transfection in ECA109 and KYSE450 cells. (b) CCK-8 assay with transfected ECA109 and KYSE450 cells to assess cell proliferation. (c) Representative EDU assay showing cell proliferation ability performed in transfected ECA109 and KYSE450 cells. (d) Representative images showing a cell apoptosis assay and flow cytometry with transfected ECA109 and KYSE450 cells. (e) Representative immunoblotting analysis showing the levels of Bax and Bcl-2 in transfected ECA109 and KYSE450 cells. (f and g) Representative transwell assay presenting cell migration and invasion rates performed in transfected ECA109 and KYSE450 cells. (h) Representative pictures depicting a cell migration assay performed by wound-healing assay with transfected ECA109 and KYSE450 cells. * p < 0.05
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 4 FIGURE Reduction of miR-1290 underlies circ_0001946-dependent phenotypes in vitro. (a) qRT-PCR revealing the miR-1290 increase efficacy of miRNA mimic introduction in ECA109 and KYSE450 cells. (b) qRT-PCR for miR-1290 expression in circ_0001946-expressing or control ECA109 and KYSE450 cells transfected with or without miR-1290 mimic or mimic NC. (c) Proliferation analysis by CCK-8 assay with circ_0001946-expressing or control ECA109 and KYSE450 cells transfected as indicated. (d) Proliferation analysis by EDU assay with circ_0001946-expressing or control ECA109 and KYSE450 cells transfected as indicated. (e) Apoptosis assessment by flow cytometry with circ_0001946-expressing or control ECA109 and KYSE450 cells transfected as indicated. (f) Representative immunoblotting analysis showing Bax and Bcl-2 levels in circ_0001946-expressing or control ECA109 and KYSE450 cells transfected as indicated. (g and h) Representative migration (g) and invasion (h) analyses by transwell assay with circ_0001946-expressing or control ECA109 and KYSE450 cells transfected as indicated. (i) Migration evaluation by wound-healing assay with circ_0001946-expressing or control ECA109 and KYSE450 cells transfected as indicated. * p < 0.05
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 6 FIGURE SOX6 is a downstream effector of miR-1290. (a) qRT-PCR showing the miR-1290 downregulation efficacy of miR-1290 inhibitor transfection. (b) Representative immunoblotting analysis revealing the transfection efficiency of si-SOX6 in suppressing SOX6. (c-j) ECA109 and KYSE450 cells were transiently introduced with si-SOX6 + miR-1290 inhibitor, si-con+miR-1290 inhibitor, miR-1290 inhibitor or inhibitor NC. (c) Representative immunoblotting analysis showing SOX6 protein level in transfected ECA109 and KYSE450 cells. (d) Proliferation analysis by CCK-8 assay with transfected ECA109 and KYSE450 cells. (e) Proliferation analysis by EDU assay with transfected ECA109 and KYSE450 cells. (f) Apoptosis assessment by flow cytometry with transfected ECA109 and KYSE450 cells. (g) Representative immunoblotting analysis showing Bax and Bcl-2 levels in transfected ECA109 and KYSE450 cells. (h and i) Representative migration (h) and invasion (i) analyses by transwell assay with transfected ECA109 and KYSE450 cells. (j) Migration evaluation by wound-healing assay with transfected ECA109 and KYSE450 cells. * p < 0.05
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 7 FIGURE Circ_0001946 affects tumor growth in vivo. (a-e) ECA109 cells were infected by circ_0001946-expressing lentivirus (lenti-circ_0001946) or control lentivirus (vector). 5 x 10 6 infected cells were hypodermically implanted into the left flanks of the BALB/c nude mice ( n = 5 per group). (a) Growth curves of the xenografts. Tumor growth was monitored for 4 weeks. (b) Images and average weight of the xenografts. (c) qRT-PCR showing the expression of circ_0001946, miR-1290 and SOX6 mRNA in the xenografts. (d) Representative immunoblotting analysis presenting SOX6 protein level in the xenografts. (e) Representative immunohistochemistry images showing ki-67, Bax, Bcl-2, MMP2, and MMP9 staining of sections of the xenografts. * p < 0.05
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2. Circ_0000285 silence lessens tumorigenic potency both in vitro and in vivo. A. RT-qPCR analysis of circ_0000285 expression in SHG-44 and U251 cells transfected with si-circ_0000285 and si-NC, vs. si-NC, **P < 0.001. B. CCK8 assays assessing the proliferation of SHG-44 and U251 cells upon circ_0000285 silence or not, vs. si-NC, **P < 0.001. C. The quantification of the invasion assay is done by counting 3 different random fields and plotted average cell number per field. D. Western blotting analysis of Bax and Bcl-2 expression in SHG-44 and U251 cells transfected with si-circ_0000285 and si-NC, vs. si-NC, **P < 0.001. E. Subcutaneous tumor growth, xenograft tumor images and tumor weights of xenografts from SHG-44 cells with or without circ_0000285 silence in nude mice, vs. si-NC, **P < 0.001. si-circ, circ_0000285 siRNA; si-NC, si-circ negative control. N = 3, repetition = 3.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 5. Cell malignant phenotypes suppressed by circ_0000285 silence is restored upon miR-197-3p inhibitor. SHG-44 and U251 cells were transfected with si-circ_0000285, si-NC, miR-197-3p inhibitor, inhibitor NC, si-circ_0000285+ miR-197-3p inhibitor. 48 h posttransfection. A. RT-qPCR analysis of miR-197-3p expression. B. Cell viability was measured with CCK8. C. Cell invasion was detected by Transwell invasion assay. D. Western blotting analysis of Bax and Bcl-2 expression. Vs.si-NC,**P < 0.001; vs.inhibitor-NC, ++ P < 0.001; vs,si-circ+inhibitor, ## P < 0.001. si-circ, circ_0000285 siRNA; si-NC, si-circ negative control; inhibitor, miR-197-3p inhibitor; inhibitor-NC, inhibitor negative control. N = 3, repetition = 3.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 7. Silencing CKS1B also compromises the malignant behaviors of glioma cells induced by miR-197-3p inhibitor. SHG-44 and U251 cells were cotransfected with si-CKS1B, si-NC, miR-197-3p inhibitor, inhibitor NC, si-CKS1B+ inhibitor. A. Western blotting analysis of CKS1B expression. B. Cell viability was measured with CCK8. C. Cell invasion was detected by Transwell invasion assay. D. Western blotting analysis of Bax and Bcl-2 expression, vs. si-NC, **P < 0.001; vs. inhibitor-NC, ++ P < 0.001; vs. si-CKS1B+inhibitor, # P < 0.05, ## P < 0.001. si-CKS1B, CKS1B siRNA; si-NC, si-CKS1B negative control; inhibitor, miR-197-3p inhibitor; inhibitor-NC, inhibitor negative control. N = 3, repetition = 3.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 8. CKS1B overexpression reversed the malignant behavior of glioma cells inhibited by circ_0000285 knockdown. SHG-44 and U251 cells were cotransfected with si-circ, si-NC, si-circ+empty vector, si-circ+OE-CKS1B. A. Western blotting analysis of CKS1B expression. B. Cell viability was measured with CCK8. C. Cell invasion was detected by Transwell invasion assay. D. Western blotting analysis of Bax and Bcl-2 expression, vs. si-NC, *P < 0.05, **P < 0.001; vs. si-circ+empty vector, #P < 0.05, ##P < 0.001. si-circ, circ_0000285 siRNA; si-NC, si-circ negative control; OE-CKS1B, CKS1B overexoression. N = 3, repetition = 3.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2 NSC-exosomes attenuates H 2 O 2 -induced neuronal apoptosis by activating autophagy in vitro. Cell apoptosis was examined by TUNEL staining (A), flow cytometry assay (B), and western blot of apoptosis markers (C). The autophagy flux was examined by immunofluorescence staining (D) and western blot of autophagy flux markers (E). The band intensities were analyzed using the gray values in Image J software.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig 5 Apoptosis is produced by activation of P73. A) Impairment of the expression of the anti-apoptotic proteins BCL-2 and XIAP is shown. B ) The decreased expression of the anti-apoptotic proteins was caspase independent, as shown by the use of Z-VAD-FMK pancaspase inhibitor. Samples were treated with 2 pulses of 40 muM of pan-caspase inhibitor, Z-VAD-FMK (R&D, Systems), to 12 and 15 h of curcumin treatment. K562 cells were harvested after 18 h, lysed and total protein extracts were obtained for western blot analysis, using specific antibodies against of Caspase-3, PARP, BCL-2 and XIAP. C ) The diminution of the expression of the antiapoptotic proteins was consistent with decreases in the IkappaBalpha and D ) activation and nuclear translocation of the P73 protein, as consequence of the E) diminished expression of the P73 promoter repressor protein C/EBPalpha; M = medium, D = DMSO.